OMA 2023 Spring Summit: The Silent Epidemic: An Overview of Non-Alcoholic Fatty Liver Disease (Recorded)

Add to Cart
- Non-member - $25.20
- Member - $21
Continue

Overview
Contents (5)

Obesity Medicine 2023 - Spring Obesity Summit - New York

CME/CE Expiration Date:4/23/2026*

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

Description:

This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition. The presentation will also review the epidemiology of non-alcoholic fatty liver disease and the initial steps in the evaluation and risk stratification of NAFLD patients presenting in a primary care setting.

Accreditation:

The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*If you have purchased the All-Access Pass and want to add this bundle to your account, please email cme@obesitymedicine.org to get access.

Key:

Complete

Next

Failed

Available

Locked

Recording

Open to view video.

Open to view video.

You must register to access.

Lecture Slides

Open to download resource.

Open to download resource.

You must register to access.

Speaker and Planner Disclosures

Open to download resource.

Open to download resource.

You must register to access.

Quiz

1 Question | 1 attempt | 0/1 points to pass

1 Question | 1 attempt | 0/1 points to pass

You must register to access.

Certificate

1.00 AMA PRA Category 1 Credit(s)™ credit | Certificate available

1.00 AMA PRA Category 1 Credit(s)™ credit | Certificate available

You must register to access.

The material presented by the Obesity Medicine Association (OMA) is for educational purposes only. Opinions expressed do not necessarily reflect those of OMA. The material is not intended to represent the only or necessarily best method or procedure appropriate for the medical situations discussed. Instead, it is intended to present an approach, view, statement, or opinion of the faculty that may be helpful to others who face similar situations. The individual is responsible for becoming familiar with laws and prescribing limitations within his or her own state before practicing various therapies. OMA also presents a forum for its members to be exposed to various products and services. It is the responsibility of each attendee or member to do due diligence, including reviewing literature, lectures, and background information.

OMA disclaims any and all liability for injury or other damages resulting to any individual viewing pages on obesitymedicine.org or academy.obesitymedicine.org and for all claims that may arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by physician or any other person.